COVID-19 – Launch of production phase of EasyCov, a saliva-based screening test, with market entry in France and Europe set for June.

The consortium formed by the biotechnology company SKILLCELL, a subsidiary of the ALCEN group, the CNRS SYS2DIAG laboratory (CNRS/ALCEN) and the digital company VOGO announces the production and marketing phases of the saliva test for the detection of SARS-COV-2 called EasyCov. There is already an efficient and reliable development, manufacture and distribution chain in place to prepare the swift deployment of the test.